Prostaglandins as inflammatory messengers across the blood-brain barrier

Journal of Molecular Medicine

Volumn 80, Issue 1, 2002, Pages 5-15

  Engblom, David ^a   Ek, Monica ^b   Saha, Sipra ^b   Ericsson Dahlstrand, Anders ^c   Jakobsson, Per Johan ^b   Blomqvist, Anders ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

Central nervous system; Cyclooxygenase 2; Interleukin 1; Prostaglandin E synthase; Prostaglandin E2

Indexed keywords

PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANOREXIA; BLOOD BRAIN BARRIER; BRAIN; CELL STRUCTURE; CHRONIC INFLAMMATION; DRUG EFFECT; DRUG SELECTIVITY; DRUG TARGETING; FEVER; HOMEOSTASIS; HYPERALGESIA; INFECTION; MEDICAL RESEARCH; NONHUMAN; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0036169270     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-001-0289-z     Document Type: Review

References (113)

1. Fever: Role of pyrogens and cryogens
2. Cytokines and the nervous system. I. Expression and recognition
3. Cytokines and the nervous system. II. Actions and mechanisms of action
4. Mechanisms of CNS response to systemic immune challenge: The febrile response
5. Antipyresis: Its effect on mortality rate of bacterially infected rabbits
6. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome
7. The pain of being sick: Implications of immune-to-brain communication for understanding pain
8. Cytokines and blood-brain barrier permeability
9. Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes
10. The vagus nerve in the thermoregulatory response to systemic inflammation
11. The contribution of the vagus nerve in interleukin-1beta-induced fever is dependent on dose
12. Multiple neural mechanisms of fever
13. The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis
14. Passage of cyto-kines across the blood-brain barrier
15. Action site of circulating interleu-kin-1 on the rabbit brain
16. Toll-like receptor 4: The missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components
17. Toll-like receptors in the induction of the innate immune response
18. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons
19. Distribution of Fos-like immunoreactivity in the rat brain following intravenous lipopolysaccharide administration
20. Suppression of fever after lesions of the anteroventral third ventricle in guinea pigs
21. Involvement of organum vasculosum of lamina terminalis and preoptic area in interleukin 1 beta-induced ACTH release
22. Activation of vagal afferents after intravenous injection of interleu-kin-1beta: Role of endogenous prostaglandins
23. Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism
24. Neurocircuitry of illness-induced hy-peralgesia
25. Subdiaphragmatic vagotomy does not block intraperitoneal lipopolysaccharide-induced fever
26. Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1
27. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
28. Microinjection of a cyclooxygenase inhibitor into the antero-ventral preoptic region attenuates LPS fever
29. Pyrogen fever and prostaglandin-like activity in cerebrospinal fluid
30. Fever produced in rabbits and cats by prostaglandin E1 injected into the cerebral ventricles
31. Further studies on prostaglandin E 1 fever in cats
32. Cyclooxygenases 1 and 2
33. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase
34. Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brain
35. The febrile response to lipopolysaccharide is blocked in cyclooxygenase- 2(-/-), but not in cyclooxygenase-1(-/-) mice
36. Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans
37. Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids
38. Characterization of inducible cyclooxygenase in rat brain
39. Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus. Inhibition by a platelet-activating factor antagonist
40. Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2
41. Cyclooxygenase-2 contributes to functional hyperemia in whisker-barrel cortex
42. Induction by lipopolysaccharide of cyclooxygenase-2 mRNA in rat brain; its possible role in the febrile response
43. Involvement of cyclooxygenase-2 in LPS-induced fever and regulation of its mRNA by LPS in the rat brain
44. Prostaglandin system in the brain: Sites of biosynthesis and sites of action under normal and hyperthermic states
45. Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain
46. Cyclooxygenase 2 mRNA expression in rat brain after peripheral injection of lipopolysaccharide
47. Inflammatory response: Pathway across the blood-brain barrier
48. Immunocytochemical detection of prostaglandin E2 in microvasculature and in neurons of rat brain after administration of bacterial endotoxin
49. Type 1 in-terleukin-1 receptor in the rat brain: Distribution, regulation, and relationship to sites of IL-1-induced cellular activation
50. Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1beta
51. Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: A view from the blood-brain barrier
52. Temporal and spatial patterns of c-fos mRNA induced by intravenous interleu-kin-1: A cascade of non-neuronal cellular activation at the blood-brain barrier
53. What is the cellular source of prostaglandins in the brain in response to systemic inflammation? Facts and controversies
54. An essential role of interleukin-1beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia
55. Endothelial cells of the rat brain vasculature express cyclooxyge-nase-2 mRNA in response to systemic interleukin-1 beta: A possible site of prostaglandin synthesis responsible for fever
56. Central induction of microsomal prostaglandin E synthase and cyclooxygenase-2 during auto-immune arthritis and other immune stimuli
57. Cyclooxygenase-2 is expressed in the vascular endothelial cells of the central nervous system during inflammatory hyperalgesia
58. Intravenous lipopolysaccharide induces cyclooxygenase 2-like immunoreactivity in rat brain perivascular microglia and meningeal macrophages
59. Differential recruitment of vascular-associated cell types to interleukin-1 versus endotoxin
60. Febrile response to tissue inflammation involves both peripheral and brain IL-1 and TNF-alpha in the rat
61. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice
62. Production of mice deficient in genes for interleukin (IL)-1alpha, IL- 1beta, IL-1alpha/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion
63. Effects of pentoxifylline and nabume-tone on the serum levels of IL- 1beta and TNFalpha in rats with adjuvant arthritis
64. Circulating interleukin-6 mediates the febrile response to localised inflammation in rats
65. Influence of interleukin-6 on neural activity and transcription of the gene encoding corticotrophin-releasing factor in the rat brain: An effect depending upon the route of administration
66. Interleukin-6 is a needed proinflammatory cytokine in the prolonged neural activity and transcriptional activation of corticotropin- releasing factor during endotoxemia
67. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity
68. The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX- 1
69. Prostaglandins and cycloxygenases in the spinal cord
70. Increased levels of cyclooxygenase-2 mRNA in the rat spinal cord after peripheral inflammation: An in situ hybridization study
71. Nociception in cyclooxygenase isozyme-deficient mice
72. Cellular localization of lipocalin-type prostaglandin D synthase (beta- trace) in the central nervous system of the adult rat
73. Identification of human prostaglandin E synthase: A microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target
74. Regulation of prostaglandin E2 biosynthesis by inducible membrane- associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2
75. Coordinate up- and down-regulation of glutathione-dependent prostaglandin E synthase and cyclooxygenase-2 in A549 cells Inhibition by NS-398 and leukotriene C4
76. Cloning, expression, and up-regulation of inducible rat prostaglandin e synthase during lipopolysaccharide-induced pyresis and adjuvant-induced arthritis
77. Coexpression of microsomal-type prostaglandin E synthase with cyclooxygenase-2 in brain endothelial cells of rats during endotoxin- induced fever
78. Eicosanoid metabolism in cerebromicrovascular endothelium
79. COX-2 as a multifunctional neuronal modulator
80. Immunology. Telling the brain about pain
81. Tumor necrosis factor-alpha inversely regulates prostaglandin D2 and prostaglandin E2 production in murine macrophages. Synergistic action of cyclic AMP on cyclooxygenase-2 expression and prostaglandin E2 synthesis
82. Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: Implications for the use of cyclooxygenase inhibitors
83. Functional coupling of cyclooxygenase 1 and 2 to discrete prostanoid synthases in liver macrophages
84. Inducible cyclooxygenase may have anti-inflammatory properties
85. New insights into the role of COX 2 in inflammation
86. Anti-inflammatory cyclopentenone pro-staglandins are direct inhibitors of IkappaB kinase
87. 15-Deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF- kappa B signaling pathway
88. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma
89. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation
90. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis
91. Differential effects of inhibition of isoforms of cyclooxygenase (COX- 1, COX-2) in chronic inflammation
92. Persistent accumulation of cyclooxygenase-1 (COX-1) expressing microglia/macrophages and upregulation by endothelium following spinal cord injury
93. Prostanoid receptors: Subtypes and signaling
94. Identification of a prostaglandin E2 receptor splice variant and its expression in rat tissues
95. Distribution, regulation and colocalization of the genes encoding the EP2- and EP4-PGE2 receptors in the rat brain and neuronal responses to systemic inflammation
96. Distribution of the EP3 prostaglandin E(2) receptor subtype in the rat brain: Relationship to sites of interleukin-1-induced cellular responsiveness
97. Distribution of prostaglandin EP(3) and EP(4) receptor mRNA in the rat parabrachial nucleus
98. Ventromedial preoptic prostaglandin E2 activates fever-producing autonomic pathways
99. Activation of prostanoid EP3 and EP4 receptor mRNA expressing neurons in the rat parabrachial nucleus intravenous injection of bacterial wall lipopolysaccharide
100. Effects of centrally administered prostaglandin EP receptor agonists on febrile and adrenocortical responses in the prepubertal pig
101. Prostaglandin E receptor EP3 subtype is involved in thermal hyperalgesia through its actions in the preoptic hypothalamus and the diagonal band of Broca in rats
102. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3
103. Prostaglandin EP3 receptor protein in serotonin and catechol-amine cell groups: A double immunofluorescence study in the rat brain
104. A functional analysis of EP4 receptor-expressing neurons in mediating the action of prostaglandin E2 within specific nuclei of the brain in response to circulating interleukin-1beta
105. EP1-receptor mediation of prostaglandin E2-induced hyperthermia in rats
106. PGE2 receptor subtype EP1 antagonist may inhibit central interleukin- 1beta-induced fever in rats
107. Prostaglandin E(2) has antinociceptive effect through EP(1) receptor in the ventromedial hypothalamus in rats
108. Relationship of EP(1-4) prostaglandin receptors with rat hypothalamic cell groups involved in lipo-polysaccharide fever responses
109. Reduced febrile responses to pyrogens after lesions of the hypothalamic paraventricular nucleus
110. Lipopolysaccharide activates specific populations of hypothalamic and brainstem neurons that project to the spinal cord
111. Hypothalamic mechanisms of pain modulatory actions of cytokines and prostaglandin E2
112. Characterization of EP receptor subtypes responsible for prostaglandin E(2)-induced pain responses by use of EP(1) and EP(3) receptor knockout mice